The Alpha 1 Project
  • The Alpha-1 Project
    • Mission and Vision
    • Projects, Partnerships and Funding
  • Alpha-1 Antitrypsin Deficiency
  • Therapeutic Strategies
  • Clinical Trial Resources
  • Progress Reports
    • Appendix
    • Partnerships
  • About Us
    • About The Alpha-1 Project
    • News
    • Scientific and Business Advisory Council
    • Contact Us
    • Documents
Accelerating Therapeutic DiscoveryTM

News From The Alpha-1 Project

25 Latest Articles Current Articles | Archives | Search

Entries for November 2019

18

Inhibrx Announces Enrollment of First Patient in Phase 1 Study of INBRX-101, a Modified Recombinant Human AAT-Fc Fusion Protein

Posted on November 18, 2019
SAN DIEGO, September 4, 2019 /PRNewswire/ — Inhibrx, Inc. (Inhibrx), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today the enrollment of the first patient in ...

[Read More...]

News Contact

For information contact:
Karen L. Erickson
Chief Operating Officer
The Alpha-1 Project
kerickson@thealpha-1project.com
telephone: 305-567-9888 ext 214

Search News

News Archives

November 2019 (1)
August 2019 (1)
July 2019 (2)
June 2019 (1)
May 2019 (1)
April 2019 (1)
January 2019 (1)
December 2018 (2)
November 2018 (1)
October 2018 (1)
August 2017 (1)
April 2016 (1)
September 2015 (1)
June 2014 (3)
January 2014 (2)
October 2013 (1)
April 2013 (1)
March 2013 (1)
December 2011 (1)

DONATE
Contact TAP CEO
for other ways to donate

Visit the Alpha-1 Foundation website

View The Alpha-1 Project Brochure

The Alpha-1 Project Alpha-1 Antitrypsin Deficiency Therapeutic Strategies Clinical Trial Resources Progress Reports About Us Login
Copyright (c) 2021 The Alpha 1 Project All Rights Reserved | Terms Of Use | Privacy Statement
The Alpha-1 Project® is a registered trademark of the Alpha-1 Foundation, Inc.
Accelerating Therapeutic Discovery™ is a registered trademark of The Alpha-1 Foundation, Inc.
Website by IMI Software, Inc.